Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DZIF-10c in SARS-CoV-2 infected and uninfected individuals
NCT04631666Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of lomtegovimab in coronavirus disease 2019 (COVID-19), sponsored by University of Cologne. Started Dec 2020; status: completed.
02
Drugs
lomtegovimab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04631666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04631666.